首页 | 本学科首页   官方微博 | 高级检索  
     

经尿道等离子前列腺切除术治疗良性前列腺增生120例
引用本文:顾恒,王昌兵,李博,余同辉,叶大文. 经尿道等离子前列腺切除术治疗良性前列腺增生120例[J]. 蚌埠医学院学报, 2011, 36(7): 728-730
作者姓名:顾恒  王昌兵  李博  余同辉  叶大文
作者单位:解放军第123医院泌尿外科, 安徽蚌埠 233015
摘    要:目的: 评价经尿道等离子前列腺切除术(TUPKRP)治疗良性前列腺增生(BPH)的安全性和疗效。方法: 经TUPKRP治疗BPH 120例,前列腺切割方法依腺体大小而定。观察手术前后国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PRV)并进行统计学分析。结果: 120例手术均获成功。手术时间30~200 min,切除前列腺组织重量10~100 g,术中出血量30~200 ml,术后膀胱持续冲洗时间2~6 d,保留尿管时间3~7 d,术后住院时间5~16 d。无手术死亡,无输血,无包膜穿孔、闭孔神经反射及经尿道电切综合征发生。术后随访3~12个月,无严重并发症。术后IPSS、QOL、Qmax、PRV均较术前有明显改善(P < 0.01)。结论: TUPKRP是治疗BPH安全有效的方法,值得临床推广应用。

关 键 词:前列腺增生   经尿道前列腺切除术   等离子
收稿时间:2011-01-12

Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia:a report of 120 cases
GU Heng,WANG Chang-bing,LI Bo,YU Tong-hui,YE Da-wen. Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia:a report of 120 cases[J]. Journal of Bengbu Medical College, 2011, 36(7): 728-730
Authors:GU Heng  WANG Chang-bing  LI Bo  YU Tong-hui  YE Da-wen
Affiliation:Department of Urology, No. 123 Hospital of PLA, Bengbu Anhui 233015, China
Abstract:Objective:To evaluate the safety and efficacy of transurethral plasmakinetic resection of prostate(TUPKRP) for treatment of benign prostatic hyperplasia(BPH).Methods:The 120 cases of BPH were treated by TUPKRP,the cutting method was performed according to the size of gland.The international prostate symptom score(IPSS),quality of life(QOL),maximum flow rate(Qmax),postvoid residual volume(PRV) of preoperation and postoperation were observed and statistically analyzed.Results:All cases were treated successfully.The operative time was 30-200 min,the weight of resected tissue was 10-100 g,the intraoperative blood loss was 30-200ml,the bladder irrigating time after operation was 2-6 d,the duration of catheter was 3-7 d,and the hospital stay after operation was 5-16 d.There was no operative death,no blood transfusion was required,and no perforation of the prostatic capsule,obturator nerve reflex and transurethral resection syndrome(TURS) occurred.All patients were followed up for 3-12 months postoperatively,there were no serious complications.The differences of IPSS,QOL,Qmax and PRV between preoperation and postoperation were statistically significances(P0.01).Conclusions:TUPKRP is a safe and effective method for treatment of BPH,it is worth popularizing.
Keywords:prostatic hyperplasia  transurethral resection of the prostate  plasmakinetic
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号